1Kurman RJ, Shih IeM. Molecular pathogenesis and extraovarianorigin of epithelial ovarian cancer - shifting the paradigm [ J ].Hum Pathol, 2011, 42(7):918-931.
2Piek JM, van Diest PJ, Zweemer RP, et al. Dysplastic changes inprophylactically removed fallopian tubes of women predisposed todeveloping ovarian cancer [ J]. J Pathol, 2001,195(4) :451 -456.
3Callahan MJ, Crum CP, Medeiros F, et al. Primary fallopian tubemalignancies in BRCA - positive women undergoing surgery for o-varian cancer risk reduction [ J ]. J of Clin Oncol,2007,25(25):3985 -3990.
4Kindelberger DW, Lee Y,Miron A,et al. Intraepithelial carcino-ma of the fimbria and pelvic serous carcinoma : evidence for acausal relationship [J]. Am J Surg Pathol, 2007, 31(2) :161 -169.
5Crum CP, Herfs M,Ning G, et al. Through the glass darkly : in-traepithelial neoplasia,top - down differentiation, and the road toovarian cancer [J]. J Pathol, 2013,231 (4) :402 -412.
6Seidman JD, Yemelyanova AV, Khedmati F, et al. Prognosticfactors for stage I ovarian carcinoma [ J] . Int J Gynecol Pathol,2010,29(1) :1 -7.
7Bakkum - Gamez JN, Richardson DL, Seamon LG, et al. Influ-ence of intraoperative capsule rupture on outcomes in stage I epi-thelial ovarian cancer [ J]. Obstet Gynecol,2009,113(1):11-17.
8Timmers PJ, Zwinderman AH, Teodorovic I,et al. Clear cell car-cinoma compared to serous carcinoma in early ovarian cancer :same prognosis in a large randomized trial [ J ]. Int J GynecolCancer, 2009,19(1) :88 -93.
9Heintz AP, Odicino F,Maisonneuve P, et al. Carcinoma of the o-vary. FIGO 26 th Annual Report on the Results of Treatment inGynecological Cancer [ J ]. Int J Gynaecol Obstet,2006,95(Suppl 1) :S161 -192.
10Ayhan A, Gultekin M, Dursun P, et al. Metastatic lymph nodenumber in epithelial ovarian carcinoma: does it have any clinicalsignificance. [ J]. Gynecol Oncol, 2008,108(2) :428 -432.
